IRS2 and Insulin resistance: The activation and regulation of SREBP-1c are mediated by insulin receptor substrate 2 (IRS-2), yet in the course of insulin resistance (IR), this receptor is downregulated, thereby leading to the overexpression of SREBP-1c and the intensification of DNL [42,48].